MIR9-1HG

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR9-1HG RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated MIR9-1HG data layer compared with 5 for mutation status and 2 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR9-1HG RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR9-1HG expression acts as an unfavorable survival marker, although some lineages such as CESC and LGG show a favorable association.

ACC, CESC, and KIRP are the cancer types where MIR9-1HG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
ACCDFSMedianAll0.2990.800<.001106view →
CESCOSMedianII,III,IV0.7310.330<.00166view →
KIRPOSTertileAll0.5380.800.00164view →
ESCADFSQuartileAll0.3730.698<.00160view →
KIRCDFSTertileII,III,IV0.3960.637<.00147view →
KICHOSMedianIII,IV0.7591.000.00547view →
THYMDFSMedianAll0.8200.962.00242view →
STADDFSTertileII,III,IV0.4870.694.00439view →
LGGOSTertileAll0.9280.818<.00133view →
MESOOSQuartileAll0.2690.529.00423view →
SKCMOSTertileIV0.5990.109.00223view →
UCECDFSQuartileAll0.8500.932.00622view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

MIR9-1HG–ACC (DFS)

Kaplan–Meier survival curve for MIR9-1HG RNA-high vs -low samples in ACC.

Open the ACC breakdown →

Exploration